Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co ElifiledCriticalLilly Co Eli
Priority claimed from PCT/US2014/021466external-prioritypatent/WO2014143601A1/fr
Publication of MA38411A1publicationCriticalpatent/MA38411A1/fr
Publication of MA38411B1publicationCriticalpatent/MA38411B1/fr
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Plural Heterocyclic Compounds
(AREA)
Abstract
La présente invention concerne des composés d'isoindolinone, ou un sel pharmaceutiquement acceptable de ceux-ci, qui inhibent la cdc7 et qui, par conséquent, peuvent être utiles dans le traitement du cancer.
MA38411A2013-03-142014-03-07Inhibiteurs de cdc7
MA38411B1
(fr)